Navigation Links
Regeneron Reports Fourth Quarter and Full Year 2012 Financial and Operating Results
Date:2/14/2013

TARRYTOWN, N.Y., Feb. 14, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial and operating results for the fourth quarter and full year 2012 and provided an update on development programs. 

The Company reported total revenues of $415 million in the fourth quarter and $1.4 billion for the year ended December 31, 2012.  Total revenues included EYLEA U.S. net product sales of $276 million in the fourth quarter and $838 million for the full year 2012.  Total revenues for the full year included a $50 million milestone payment from Sanofi and $25 million of milestone payments from Bayer HealthCare in connection with regulatory approvals of ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion and EYLEA (aflibercept) Injection for Intravitreal Injection, respectively, as described below. 

The Company reported non-GAAP net income of $171 million, or $1.47 per diluted share, in the fourth quarter and $530 million, or $4.66 per diluted share, for the year ended December 31, 2012.  Non-GAAP net income excludes non-cash share-based compensation expense, non-cash interest expense related to the Company's convertible senior notes, and a non-cash tax benefit of $336 million recorded during the fourth quarter primarily as a result of releasing substantially all of the valuation allowance associated with the Company's deferred tax assets as of December 31, 2012.  The Company reported GAAP net income of $470 million, or $4.08 per diluted share, in the fourth quarter and $750 million, or $6.75 per diluted share, for the full year 2012. 

"2012 was truly a transformative year for Regeneron as strong U.S. net sales of EYLEA drove our first full year of profitability on a GAAP and non-GAAP basis," said Leonard S. Schleifer, M.D., Ph.D., President and Chief Exec
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Regeneron Announces Receipt of Hart-Scott-Rodino Notice
2. Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013
3. Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
4. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
5. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
6. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
7. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
8. Regeneron Announces September 2012 Investor Conference Presentations
9. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
10. Regeneron Announces June 2012 Investor Conference Presentations
11. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... N.J. , Feb. 27, 2015  Acsis Inc., ... and serialization solutions, announced today that John DiPalo ... a Supply & Demand Chain Executive 2015 ... executives who are leading initiatives to help prepare their ... of today,s business climate. This year,s list of Provider ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 ... EPI) and Bloom Burton & Co. Ltd. ("Bloom Burton") ... lock-up (the "Lock-Up") 2,353,130 common shares of the Company ... subject to the Lock-Up. Of the Common Shares released ... immediately upon release from the Lock-Up while the remainder ...
(Date:2/27/2015)... Feb. 27, 2015  In recognition of Rare Disease ... the global bleeding disorders community, CSL Behring ... units (IUs) of protein therapies to the World Federation ... organization which has worked to improve the lives of ... donation supports the WFH,s Global Alliance for Progress (GAP) ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3
... THOUSAND OAKS, Calif., Nov. 4 Amgen (Nasdaq: ... for its 19th annual Amgen Award for Science Teaching ... and honor extraordinary science teachers at the K-12 level ... and who achieve demonstrated results in student learning in ...
... (NYSE Amex: NBS ), announced today that Edward ... Board of Directors. Dr. Geehr brings extensive experience ... as Executive Vice President of Operations, Dr. Geehr was ... a global biotechnology company dedicated to the discovery, development ...
Cached Medicine Technology:Call for Applications: The Amgen Award for Science Teaching Excellence 2Call for Applications: The Amgen Award for Science Teaching Excellence 3NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations 2NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations 3
(Date:2/27/2015)... February 27, 2015 On February 24 2015, ... Liquid Botox ,” that details the development of RT001, ... working its way through FDA trials. For those afraid of ... is very attractive. Of course, if the drug ultimately gets ... a physician’s office. (see: goo.gl/PQvQwk) , “As the article notes, ...
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 Winter is ... like on human skin, exposure to snow and ice can ... can also hurt dogs’ paws. The Puppy Store is ready ... to keep their dogs safe in the winter time. , ... causing vomiting, diarrhea and other symptoms. Ingestion of ice melt ...
(Date:2/27/2015)... Victorian Hotel recently celebrated Valentine’s Day ... wanted to spend the auspicious day together. This Vancouver ... jump on Valentine’s Day with a sweet overnight package, ... their luxurious rooms. , The hotel started its ... a mouthwatering 3 course meal at Café 335. This ...
(Date:2/27/2015)... Mediaplanet today announces the launch of its second cross-platform ... bring blood health and cancer awareness to the forefront ... edition go beyond the concept of these insidious diseases ... and technological strides needed to develop new solutions and ... every 3 minutes one person in the United ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The ... has announced a scholarship for rising freshmen undergraduate students. ... leading periodontist office specializing in many periodontal procedures such ... treatment of gum disease . In honor of ... college scholarship for eligible rising freshmen undergraduate students. ...
Breaking Medicine News(10 mins):Health News:Is Topical Botox the Next Big Thing? 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2
... Binge drinking may not necessarily kill or even damage brain ... But it can block key receptors in the brain and ... critical to learning and memory, according to researchers. Neuroscientists ... their findings not only shed light on exactly what is ...
... Of 180 patients in this study in whom a ... had originally been misdiagnosed by their family doctors as ... colleagues present the results of their cross-sectional study in ... (Dtsch Arztebl Int 2011; 108[26]: 445-51). When a ...
... Misinformation about venomous spiders and spider bites often leads emergency ... creatures for "necrotic" skin lesions, new research indicates. Necrotic ... die due to a lack of blood and oxygen, and ... necrotic lesions on the skin are typically not the result ...
... patients and for the first time researchers have found ... heart failure outcomes, a highlight of the recent American ... was the need to establish the mechanisms by which ... Christopher S. Lee, PhD, RN of the Oregon ...
... July 13 (HealthDay News) -- Rural workers are often forced to ... and their jobs, researchers report. According to the study ... New Hampshire, people who work in rural communities have less access ... or lost jobs and caring for themselves or a family member ...
... that are designed to suppress the formation of new ... slowed cancer growth in some patients. However, they have ... might. Now, research from the Perelman School of Medicine ... the modest responses. The discovery, published in the July ...
Cached Medicine News:Health News:Rat Study Shows How Binge Drinking Harms Memory 2Health News:Skin Lesions Often Misdiagnosed as Spider Bites 2Health News:Heart failure: Doing what your doctor says works 2Health News:Rural Workers Often Lack Access to Sick Leave 2Health News:Penn study shows link between immune system suppression and blood vessel formation in tumors 2
... surgical stretcher. M-701 Stretcher has a ... to 32 in., measured with a ... a high range, 28 in. to ... pad can be supplied optionally. Vinyl ...
... is a staining solution for cataract ... for performing a safe phaco-emulsification procedure. ... capsule may result in an incomplete ... of radial capsule tears and associated ...
... dye, used in matured cataract surgery, which ... enables the surgeon to see capsule ... trypan blue combined with sodium chloride and ... intraocular injection into the anterior chamber of ...
Blanket protection against heavier bleeding....
Medicine Products: